Bendamustine Hydrochloride Patents

Given below is the list of patents protecting Bendamustine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Bendamustine Hydrochloride's patents.

Latest Legal Activities on Bendamustine Hydrochloride's Patents

Given below is the list recent legal activities going on the following patents of Bendamustine Hydrochloride.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 8th Year, Large Entity	20 Jun, 2024	US9533955
Payment of Maintenance Fee, 12th Year, Large Entity	19 Jun, 2024	US8344006
Email Notification Critical	20 Dec, 2023	US11844784
Recordation of Patent Grant Mailed Critical	19 Dec, 2023	US11844784
Patent eGrant Notification	19 Dec, 2023	US11844784
Mail Patent eGrant Notification	19 Dec, 2023	US11844784
Patent Issue Date Used in PTA Calculation Critical	19 Dec, 2023	US11844784
Recordation of Patent eGrant	19 Dec, 2023	US11844784
Email Notification Critical	30 Nov, 2023	US11844784
Issue Notification Mailed Critical	29 Nov, 2023	US11844784

Bendamustine Hydrochloride's Family Patents

Full family tree